Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	4,526	4,465	3,043	2,939	2,601	1,828
Market Cap Growth	-20.03%	46.74%	3.52%	13.02%	42.23%	25.34%
Enterprise Value	4,446	3,709	2,488	2,474	2,149	1,172
Last Close Price	1025.50	998.56	668.58	633.75	526.89	363.00
PE Ratio	13.72	13.93	11.71	11.95	11.66	11.08
PS Ratio	2.85	2.94	2.14	2.15	2.10	1.67
PB Ratio	2.47	2.60	2.10	2.40	2.22	1.86
P/TBV Ratio	2.48	2.60	2.11	2.40	2.22	1.87
P/FCF Ratio	-	54.50	54.63	19.66	41.83	9.99
P/OCF Ratio	16.02	16.00	37.46	17.24	28.05	9.40
EV/Sales Ratio	2.80	2.44	1.75	1.81	1.73	1.07
EV/EBITDA Ratio	10.70	9.33	7.67	8.28	8.04	6.15
EV/EBIT Ratio	11.48	9.84	8.08	8.78	8.45	6.58
EV/FCF Ratio	-264.78	45.28	44.68	16.55	34.56	6.40
Debt / Equity Ratio	0.01	0.02	-	0.02	0.06	0.05
Debt / EBITDA Ratio	0.04	0.10	-	0.10	0.25	0.26
Debt / FCF Ratio	-	0.48	-	0.20	1.09	0.28
Asset Turnover	0.81	0.84	0.93	0.96	0.94	0.97
Inventory Turnover	3.26	3.53	3.71	3.71	3.67	3.32
Quick Ratio	1.56	2.39	6.01	4.48	3.00	3.91
Current Ratio	2.17	3.00	6.70	5.15	3.57	4.45
Return on Equity (ROE)	19.38%	20.25%	19.43%	20.52%	20.66%	18.49%
Return on Assets (ROA)	12.39%	13.04%	12.54%	12.37%	12.04%	9.87%
Return on Invested Capital (ROIC)	17.02%	24.19%	30.98%	27.52%	29.42%	33.06%
Return on Capital Employed (ROCE)	20.60%	21.20%	20.70%	22.40%	20.90%	17.30%
Earnings Yield	7.29%	7.18%	8.54%	8.37%	8.57%	9.03%
FCF Yield	-0.37%	1.84%	1.83%	5.08%	2.39%	10.01%
Dividend Yield	1.70%	1.80%	2.29%	2.27%	2.28%	2.81%
Payout Ratio	24.21%	21.15%	24.32%	22.35%	20.99%	-
Buyback Yield / Dilution	-0.01%	-	3.34%	0.52%	-	-
Total Shareholder Return	1.69%	1.80%	5.63%	2.79%	2.28%	2.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.